Effects of Ulinastatin on Peripheral Blood T Cell Subsets CD95 Expression and Plasma Sicam-1, IL-8 Levels During Perioperative Renal Transplantation

龚华,刘志宏,祝捷,范昱

DOI: https://doi.org/10.3969/j.issn.1671-4695.2011.09.003

2011-01-01

Abstract:Objective To analyse the effects of ulinastatin on peripheral blood T cell subsets CD95 expression and plasma sICAM-1,IL-8 levels during perioperative renal transplantation,and explore the mechanism of ulinastatin improving postoperative kidney function and regulation of immune function.Methods Fifty-one patients(ASA Ⅱ-Ⅲ) received selective renal transplantation were randomly divided into two groups: ulinastatin group(n=26) and control group(n=25).Blood samples were taken from central vein before anesthesia,on the 7th day and 14th day after operation for determination of peripheral blood T cell subsets CD95 expression and plasma sICAM-1,IL-8 levels.Results The peripheral blood T cell subsets CD95 expression and plasma sICAM-1,IL-8 levels significantly increased on the 7th and 14th day after operation than baseline value(P0.01).The peak appeared on the 7th day after operation,but on the 14th day after operation,the CD95 expression levels and serum sICAM-1,IL-8 levels still higher than baseline(P0.05).The increasing amplitude of CD95 expression level and plasma sICAM-1,IL-8 levels in ulinastatin group was lower than control group(P0.05).Conclusion Ulinastatin may effectively reduce the expression of CD95 during perioperative renal transplantation,and restore patient's cell immunity function;furthermore,ulinastatin effectively reduce serum levels of sICAM-1 and IL-8,which may have protective effects on renal ischemia reperfusion injury during renal transplantation.